
1ÔÂ7ÈÕ£¬£¬£¬£¬£¬ÉúÎïÖÆÒ©¹«Ë¾CinCor Pharma£¨¹ÉƱ´úÂëΪ£º¡°CINC¡±£©ÔÚÃÀ¹úÄÉ˹´ï¿ËÉÏÊУ¬£¬£¬£¬£¬¿¯ÐмÛΪ16ÃÀÔª¡£¡£¡£¡£
CinCor Pharma´Ë´Î¿¯ÐÐ1210Íò¹É£¬£¬£¬£¬£¬Ä¼×Ê1.92ÒÚÃÀÔª¡£¡£¡£¡£
CinCor Pharma¿ªÅ̼ÛΪ21ÃÀÔª£¬£¬£¬£¬£¬½Ï¿¯ÐмÛÉÏÕÇ31.25%£»£»£»CinCor PharmaÊÐֵΪ7.25ÒÚÃÀÔª¡£¡£¡£¡£
9¸öÔ¾»¿÷Ëð2103ÍòÃÀÔª

CinCor PharmaÊÇÒ»¼Ò¸ßѪѹ°ÐÏòÖÎÁÆÒ©ÎïÑз¢ÉÌ£¬£¬£¬£¬£¬¸Ã¹«Ë¾µÄÖÆÒ©ÁìÓòΪÐÄѪ¹Ü¡¢´úлºÍÉöÔ༲²¡¡£¡£¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬CinCor PharmaµÄÖ÷Òª²úÆ·ÊÇCIN-107£¬£¬£¬£¬£¬ÊÇÒ»ÖÖøÒÖÖÆ¼Á£¬£¬£¬£¬£¬°ÐÏòÖÎÁÆ¿¹Ò©ÐÔ¸ßѪѹ¡£¡£¡£¡£
ÕйÉÊéÏÔʾ£¬£¬£¬£¬£¬CinCor PharmaÏÖÔÚÎÞÓªÊÕ£¬£¬£¬£¬£¬2019Äê¡¢2020Äê»®·ÖÔËÓª¿÷ËðΪ514ÍòÃÀÔª¡¢2113ÍòÃÀÔª£»£»£»CinCor PharmaÔÚ2021Äêǰ9¸öÔÂÔËÓª¿÷ËðΪ1728ÍòÃÀÔª£¬£¬£¬£¬£¬ÉÏÄêͬÆÚµÄÔËÓª¿÷ËðΪ1561ÍòÃÀÔª¡£¡£¡£¡£
CinCor PharmaÔÚ2019Äê¡¢2020Äê»®·Ö¾»¿÷ËðΪ504ÍòÃÀÔª¡¢2230ÍòÃÀÔª£»£»£»2021Äêǰ9¸öÔ¾»¿÷ËðΪ2103ÍòÃÀÔª£¬£¬£¬£¬£¬ÉÏÄêͬÆÚµÄ¾»¿÷ËðΪ1649ÍòÃÀÔª¡£¡£¡£¡£
¸ÕÍê³É1.43ÒÚÃÀÔªÈÚ×Ê
2019Äê5Ô£¬£¬£¬£¬£¬CinCor PharmaÔøÐû²¼Íê³É5000ÍòÃÀÔªAÂÖÈÚ×Ê£¬£¬£¬£¬£¬ÓÉSofinnova InvestmentsÁìͶ£¬£¬£¬£¬£¬5AM Ventures¸úͶ¡£¡£¡£¡£
2021Äê10Ô£¬£¬£¬£¬£¬CinCor PharmaÐû²¼Íê³É1.43ÒÚÃÀÔªµÄBÂÖÈÚ×Ê£¬£¬£¬£¬£¬ÓÉÉú³¤Ð͹ÉȨ¹«Ë¾General AtlanticÁìͶ£¬£¬£¬£¬£¬ÐÂͶ×ÊÕß Perceptive Advisors¡¢BVF Partners¡¢venBio Partners¡¢Adage Capital Management¡¢Omega Funds¡¢Rock Springs Capital¡¢RTW Investments¡¢Lilly Asia Ventures ºÍ Sixty degree Capital¼ÓÈë´Ë´ÎÈÚ×Ê¡£¡£¡£¡£
IPOǰ£¬£¬£¬£¬£¬Sofinnova Venture Partners X, L.P.³Ö¹ÉΪ22.3%£¬£¬£¬£¬£¬Sofinnova Venture IX³Ö¹ÉΪ16.4%£¬£¬£¬£¬£¬5AM Ventures VI³Ö¹ÉΪ16.4%£»£»£»
CinRx Pharma³Ö¹ÉΪ12.1%£¬£¬£¬£¬£¬General Atlantic³Ö¹ÉΪ10.3%£¬£¬£¬£¬£¬James I. Healy, M.D., Ph.D.³Ö¹ÉΪ22.4%¡£¡£¡£¡£
IPOºó£¬£¬£¬£¬£¬Sofinnova Venture Partners X, L.P.³Ö¹ÉΪ14.8%£¬£¬£¬£¬£¬Sofinnova Venture IX³Ö¹ÉΪ10.9%£¬£¬£¬£¬£¬5AM Ventures VI³Ö¹ÉΪ10.9%£»£»£»
CinRx Pharma³Ö¹ÉΪ8.1%£¬£¬£¬£¬£¬General Atlantic³Ö¹ÉΪ6.9%£¬£¬£¬£¬£¬James I. Healy, M.D., Ph.D.³Ö¹ÉΪ14.9%¡£¡£¡£¡£
Ææ·¢28
Ææ·¢28£¨ÃÀ¹úÉÏÊÐ¹ÉÆ±´úÂëWFHG£©£¬£¬£¬£¬£¬ÊÇÒ»¼ÒרҵÐÖúÆóÒµÔÚº£ÄÚÍâÉÏÊÐÈÚ×ʽøÈë×ÊÔ´Êг¡µÄÈ«·½Î»×ÊÔ´ÔË×÷ЧÀÍ»ú¹¹¡£¡£¡£¡£º¬Ïòµ¼ÉÏÊС¢¶¥²ãÉè¼Æ¡¢ÊÐÖµ¹ÜÀí¡¢Í¶×ÊÈÚ×Ê¡¢²¢¹ºÖØ×éµÈ£¬£¬£¬£¬£¬Ææ·¢28¶À´´IAPOÉÏÊÐģʽ£¬£¬£¬£¬£¬Æ¾Ö¤ÆóÒµµÄÏÖÕæÏàÐΣ¬£¬£¬£¬£¬ÍýÏë×îºÏÊʵÄÉÏÊз¾¶£¬£¬£¬£¬£¬Ìá¸ßÆóÒµÉÏÊÐÀÖ³ÉÂÊ¡£¡£¡£¡£
Ææ·¢28Ïà¹ØµÄ»¥Áª¼Ò»ù½ð£¬£¬£¬£¬£¬ÍŶÓ×Ô99Äê´ÓÊ»ù½ð¹ÜÀíÖÁ½ñ£¬£¬£¬£¬£¬ÏÖÔÚÓµÓлù½ð¹ÜÀíÅÆÕÕ£º½ËÕ»¥Áª¼Ò»ù½ð¹ÜÀíÓÐÏÞ¹«Ë¾£¨P1070824£©¡¢ÉîÛÚ½ðש¹«ÓÃ×ʲú¹ÜÀíÓÐÏÞ¹«Ë¾£¨P1030533£©£¬£¬£¬£¬£¬Ö÷Óª¡°¹ÜÀí¹ÉȨͶ×Ê»ù½ð¡¢Õþ¸®Ö¸µ¼»ù½ð¡¢¹¤ÒµÍ¶×Ê»ù½ð¡¢´´ÒµÍ¶×Ê»ù½ð£¬£¬£¬£¬£¬×ʲú¹ÜÀí¡¢Í¶×ʹÜÀí£¬£¬£¬£¬£¬´´ÒµÍ¶×Ê¡±µÈÓªÒµ¡£¡£¡£¡£±¾»ù½ðΪ˽ļ¹ÉȨ»ù½ð£¬£¬£¬£¬£¬ÔÚ¹ÜÀíʵ½É»ù½ð¹æÄ£Áè¼Ý200ÒÚÔª£¬£¬£¬£¬£¬ÀۼƹÜÀíʵ½É¹æÄ£Áè¼Ý634.896ÒÚÔª¡£¡£¡£¡£Ö÷Òª°üÀ¨°ÍÖÐÊС¢Â¦µ×ÊС¢ÆÕ¶ýÊС¢ÇàÍÏ¿ÊС¢¹óÑôÊС¢°ÙÉ«ÊеÈ16¸ö¶¼»áÕþ¸®Í¶×Ê»ù½ð¡£¡£¡£¡£Àֳɷõ»¯Í˳ö52¼ÒÆóÒµ£¬£¬£¬£¬£¬Ö±½ÓIPOÉÏÊаüÀ¨Éе¹ɷݡ¢°²¿ÆÉúÎï¡¢»ª¹â¹øÂ¯¡¢¼ªöοƼ¼ºÍ°®¿µ¹É·ÝµÈ24¼Ò¿Æ¼¼ÐÍÆóÒµÀÖ³ÉÉÏÊУ¬£¬£¬£¬£¬²¢Í¨¹ý×ÊÔ´ÔËÓªÔöֵЧÀÍÍÆ¶¯Ïà¹ØÆóÒµ³ÉΪ¹ú¼Ê£¨»òº£ÄÚ£©Ï¸·ÖÐÐÒµÁúÍ·£¬£¬£¬£¬£¬ÆäÖÐÁ½¼ÒÔø±»ÁÐÈë¹þ·ð´óѧºÍÇ廪´óѧ½Ìѧ°¸Àý¡£¡£¡£¡£
Ææ·¢28¿Ø¹ÉµÄÉϺ£¿£¿£¿Ø±¾ÆóÒµ¹ÜÀíÓÐÏÞ¹«Ë¾ÎªÉÏÊÐÅäÌ×ЧÀÍ»ú¹¹£¬£¬£¬£¬£¬Ö÷Ӫ֪ʶ²úȨ³ö×ÊÓë×ÊÔ´ÔË×÷ÓªÒµ£¬£¬£¬£¬£¬ÖúÁ¦ÆóÒµÇáËÉÈÚ×Ê£¬£¬£¬£¬£¬¿ìËÙÉÏÊС£¡£¡£¡£Ææ·¢28ÔÚÃÀ¹ú¡¢Ó¢¹ú¡¢ÉϺ£¡¢Î÷°²µÈµØÉèÁ¢°ì¹«ÊÒ£¬£¬£¬£¬£¬ÒÀÍн¼Ò×ìCBDÉÌÎñ°æ¿é£¬£¬£¬£¬£¬»ã¾ÛÈ«Çò¸÷ÐÐÒµ¾«Ó¢Ç̳þ£¬£¬£¬£¬£¬ÍŶӾßÓÐÊýÊ®ÄêͶÈÚ×Ê¡¢ÆóÒµÉÏÊС¢×ÊÔ´ÔË×÷Àֳɰ¸Àý£¬£¬£¬£¬£¬ÒÑ×ÊÖúÖÚ¶àÆóÒµ»ñµÃÈÚ×ÊÉÏÊУ¬£¬£¬£¬£¬³ÉΪ×ÅÃûÆóÒµ¡£¡£¡£¡£
ȪԴ£ºÀ×µÝÍø ÊÀ½ç½ð¿ØÃ½×ʲ¿ÕûºÏ±à¼
? ÃâÔðÉùÃ÷£º±¾Æ½Ì¨ÄÚÈݲ¿·ÖȪԴÓÚÍøÂ磬£¬£¬£¬£¬ÐÅÏ¢½ö¹©²Î¿¼£¬£¬£¬£¬£¬±¾Æ½Ì¨²»¼ç¸ºÔðÈΡ£¡£¡£¡£ÈôÊÇÇÖÕ¼ÄúµÄÈ¨ÒæÇëʵʱ¼û¸æÎÒÃÇ£¬£¬£¬£¬£¬ÎÒÃǽ«ÓÚµÚһʱ¼äɾ³ý¡£¡£¡£¡£